Rigel Pharmaceuticals (RIGL) Set to Report Q4 FY2025 Earnings After the Bell — Here’s What to Expect
Consensus Estimates Metric Q4 FY2025 Estimate Q4 FY2024 Actual YoY Change Revenue ~$75–85M ~$57.6M +30-48% EPS ~$1.60–1.80 ~$0.8 Significant expansion ...
